An Analysis of Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer by 杉, 素彦 et al.
Title膀胱全摘後の上部尿路再発の臨床的検討
Author(s)杉, 素彦; 福井, 勝也; 吉田, 健志; 乾, 秀和; 川喜多, 繁誠; 室田, 卓之; 木下, 秀文; 松田, 公志








杉 素彦1，福井 勝也2，吉田 健志2，乾 秀和1
川喜多繁誠1，室田 卓之1，木下 秀文2，松田 公志2
1関西医科大学滝井病院，2関西医科大学枚方病院
AN ANALYSIS OF UPPER URINARY TRACT RECURRENCE
FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER
Motohiko Sugi1, Katsuya Fukui2, Kenji Yoshida2, Hidekazu Inui1,
Shigenari Kawakita1, Takashi Murota1, Hidehumi Kinoshita2 and Tadashi Matsuda2
1The Department of Urology, Kansai Medical University Takii Hospital
2The Department of Urology, Kansai Medical University Hirakata Hospital
Transitional cell carcinoma of the urothelium is often multifocal, and subsequent tumors may occur
anywhere in the urinary tract afer treating the initial carcinoma. The risk of an upper urinary tract
recurrence following a radical cystectomy has been reported to be approximately 2 to 8%, but there are few
reports with regard to the pattern and predictive factors of upper tract recurrence. We report here the
incidence and pattern of upper tract recurrence following a radical cystectomy. Of the 166 patients 5 (3%)
had upper tract recurrence. The prognosis of upper urinary tract recurrence is significantly better than
other site of recurrence.
(Hinyokika Kiyo 56 : 87-90, 2010)









対 象 と 方 法
1990年 1 月から2008年 5 月までに関西医大滝井病
院，関西医大枚方病院で施行した膀胱全摘166例を対
象とした．膀胱全摘後の経過観察は尿細胞診，IVP，
CT を 3∼ 6カ月おきに施行し再発，転移の有無を確
認した．観察期間は手術日を起算日とし，上部尿路に
再発した 5例について臨床的検討を行った．有意差検










であった．上部尿路に再発した症例は 5 例（ 3％）
で，再発までの期間は中央値44カ月（11∼76カ月）で
あった．再発症例の尿路変向は回腸導管 4例，回腸新
膀胱 1例で，再発部位は左腎盂 2例，左尿管 1例，右
Table 1. Patient demographics at cystectomy
Median age at surgery (range) 68 (43-91)
Median mos to urinary upper tract recurrence
(range) 44 (11-76)
Pathological stage (％)
pT0 4 ( 2)





pTis 4 ( 2)




Prostatic involvement ＋ 13 ( 8)
Urethral involvement ＋ 3 ( 2)
Ureteral involvement ＋ 3 ( 2)
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1 60 45 pT1N0-G2 ─ ─ ─ ─ Suspect 44 rt ureter ─ ─ DoD
2 86 22 pT1N0-G3 ＋ ─ ─ ─ Negative 11 lt pelvis NxUx pT3NX NED
3 74 78 pT0＋PC-G2 ＋ ＋ ─ ─ Positive 68 lt ureter NxUx pTisNX NED
4 57 125 pT1N0-G3 ─ ─ ─ ─ Unknown 76 rt ureter NxUx pT1N0 NED
5 70 54 pT4N0-G3 ＋ ─ ─ ─ Positive 20 lt pelvis NxUx pT3NX NED
Cx : cystectomy, NxUx : nephroureterectomy, u : ureter, pr : prostate, ur : urethra, DoD : dead of disease, NED : no evidence of disease.
Table 3. Localization and characteristics of recurrences
Localization
p value
UUTR Other site of recurrence
No patients 5 47, pelvis 4, lymph nodes 13, lung 12, liver 9, bone 6, urethra 2,penis 1, skin 2, unknown 2
Time to progression median (range) months 44 (11-76) 8 (1-129) 0.0048
＜3 years/3 years＜
(early)/(late) 3/5 45/2
Alive (survival ％) 4 (80) 10 (20.4) 0.0153
泌56,02,03-2
Fig. 2. Cause-specific survival curve according to location of recurrences.
泌56,02,03-1
Fig. 1. Relapse time of UUTR and other site of
recurrence.
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(Table 3），非再発期間は，その他の部位では 3 年以














は 5例中 2例が陽性で， 1例は疑陽性であった． 5例
































































2 27/1,069 (2.5) 41 (17-106) 23/4 40 (5-112) Urethral involvement 13/12 9/18 DOD 33.3
4 16/529 (3) 49.2 (4.4-87.7) 7/9 37.2 (4-77.4) Not specified 4/ 5 4 (3AWD)/11 DOD, 1DOAD 25
9 26/568 (4.6) 18 (3-103) 25/9 69 Superficial TCC 10 (2 AWD)/14 DOD 38.5
10 15/225 (6.7) 8/7 18.3 (6-37)/28.3 (8-54) CIS
11 11/430 (2.6) 12 (1-85) 8/3 40 (9-56) Ureteral involvement 4/ 4 6 (2 AWD)/5 DOD 54.5
12 5/61 (8.2) 4/1 68 (34-118) Not specified
13 2/85 (2.4) 42 (5-149) 2/0 76/48 Not specified 1/ 1 1/1 DOAD 50
14 5/235 (2.1) 57 (36-72) 5/0 36 (16-60) Urethral involvement 2/ 1 1/4 DOD 20
15 9/382 (2.4) 4/5 25 (5-111) Not specified
16 10/483 (2.1) Ureteral involvement 4/6 DOD 40
17 12/583 (2.1) 41.5 (7-77) 9/3 29.5 (5-71) Multiplicity 6/ 1 4 (2AWD)/8 DOD 33.3
18 80/1,329 (6) 38 (17-70) 25.2 (1-107) Ureteral involvement 80/0 100
19 6/188 (3) 5/1 27.3 5/ 1 3/2 DOD, 1 DOAD 50
20 14/425 (3.3) 75 (60-105) 12/2 42 (8-100) 5/ 5 3/11 DOD 21.4
21 5/210 (2.4) 4/1 3/ 2 0/5 0
UUTR : upper urinary tract recurrence, AWD : alive with disease, DOD : dead of disease, DOAD : dead of another disease.
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